Select a medication above to begin.
Azstarys
serdexmethylphenidate/ dexmethylphenidate
Black Box Warnings .
Abuse, Misuse, and Addiction
CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, incl. addiction; misuse and abuse can result in overdose and death, risk incr. w/ higher doses or unapproved admin. methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate pts and families about risks and proper drug storage and disposal; monitor frequently for s/sx of abuse, misuse, and addiction during tx
Adult Dosing .
Dosage forms: CAP: 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg
Special Note
- [formulation clarification]
- Info: not interchangeable w/ other methylphenidate products; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [26.1 mg/5.2 mg-52.3 mg/10.4 mg PO qam]
- Start: 39.2 mg/7.8 mg PO qam x1wk, then may incr. to 52.3 mg/10.4 mg PO qam; Max: 52.3 mg/10.4 mg/day
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: CAP: 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg
Special Note
- [formulation clarification]
- Info: not interchangeable w/ other methylphenidate products; do not substitute on a mg to mg basis; retitrate if switching between products
ADHD
- [6 yo and older]
- Dose: 26.1 mg/5.2 mg-52.3 mg/10.4 mg PO qam; Start: 39.2 mg/7.8 mg PO qam x1wk, then may incr. to 52.3 mg/10.4 mg PO qam; Max: 52.3 mg/10.4 mg/day
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]